Humco Launches Line of Repackaged Active Pharmaceutical Ingredients
AUSTIN, April 18, 2016/– Humco, a diversified global pharmaceutical company, announced the launch of twenty-four repackaged Active Pharmaceutical Ingredients (APIs) in key therapeutic categories including Pain Management, Infectious Disease, and Hormone Replacement Therapy. Humco’s API launch brings the highest levels of quality to hospitals and compounding pharmacies in a variety of conveniently packaged sizes.
“We are thrilled to launch our API portfolio to our customers around the world. We believe with our stringent quality and testing standards that we can provide increased value to patients and pharmacies,” said Andrew Pulido, Humco’s President, Global Pharmaceuticals.
Humco performs thorough testing for identification and potency on each lot of API received. In addition to identifying that the correct active ingredient was received, Humco also ensures comprehensive testing to validate that the API is pure, as required through potency testing. Humco is confident that their analytical scrutiny has helped dismiss suppliers that do not meet their high standards of quality.
For a full list of APIs, please visit www.humco.com.
Humco, founded in 1872, is a diversified global pharmaceutical company. Humco is focused on developing, manufacturing and commercializing innovative pharmaceuticals and high-quality over-the-counter (OTC) medicines for patients around the world.
With headquarters in Austin, TX, Humco serves over 45,000 pharmacies through its Pharmaceutical Segment and its Consumer OTC Products franchise. The Company is anchored by its leading non-sterile compounding delivery vehicles, including topical and transdermal creams, syrups, and suspensions. Humco also serves consumers through its established and diverse Consumer OTC Products business of over 160 items with product placement in all major drug, food, and mass-market retail chains, along with independent, locally owned pharmacies.
Humco’s leading team of professionals have strong expertise ranging from product development to commercialization in the Company’s state-of-the-art FDA registered, cGMP compliant facilities.
With a presence in approximately 20 countries, Humco is committed to working with pharmacists, physicians, healthcare providers and patients to deliver innovative and meaningful treatments that help people around the world live longer, healthier lives.
For more information, visit Humco’s website at www.humco.com.
+1 (512) 474-7400
+1 (903) 334-6206
SOURCE: Humco, Inc.